30 Recruiting Studies Using Talazoparib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Talazoparib
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
📍 University of Alabama at Birmingham — Birmingham, Alabama
Prostate Cancer
View Study & Checklist ➔Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
📍 Brigham and Women's Hospital — Boston, Massachusetts
Metastatic Prostate Cancer
View Study & Checklist ➔Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
📍 Alaska Urological Institute dba Alaska Clinical Research Center — Anchorage, Alaska
mCRPC
View Study & Checklist ➔Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Leukemia
View Study & Checklist ➔Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Extensive Stage Lung Small Cell Carcinoma
View Study & Checklist ➔Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
📍 University of Chicago — Chicago, Illinois
Metastatic Endometrial Cancer
View Study & Checklist ➔Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
📍 UF Health Cancer Institute - Gainesville — Gainesville, Florida
Anatomic Stage III Breast Cancer AJCC v8
View Study & Checklist ➔Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
📍 Northwestern University Feinberg School of Medicine — Chicago, Illinois
TNBC - Triple-Negative Breast Cancer
View Study & Checklist ➔Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
Advanced Malignancies
View Study & Checklist ➔Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Neoplasm
View Study & Checklist ➔Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Breast Cancer
View Study & Checklist ➔Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
Malignant Solid Neoplasm
View Study & Checklist ➔TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
Breast Cancer
View Study & Checklist ➔Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
📍 CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center — Bakersfield, California
Recurrent Extensive Stage Small Cell Lung Carcinoma
View Study & Checklist ➔A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
📍 City of Hope — Duarte, California
Prostate Cancer (Adenocarcinoma)
View Study & Checklist ➔Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
Castration-Sensitive Prostate Carcinoma
View Study & Checklist ➔A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Endometrial Cancer
View Study & Checklist ➔I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Neoplasms
View Study & Checklist ➔Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Prostate Cancer
View Study & Checklist ➔Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
📍 Lucille Packard Children's Hospital Stanford — Palo Alto, California
Recurrent Solid Tumor
View Study & Checklist ➔Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
📍 UCSF Medical Center-Mission Bay/Benioff Children's Hospital — San Francisco, California
Breast Cancer
View Study & Checklist ➔Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
📍 University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
Ovarian Cancer
View Study & Checklist ➔Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
📍 Johns Hopkins University/Sidney Kimmel Cancer Center — Baltimore, Maryland
Malignant Female Reproductive System Neoplasm
View Study & Checklist ➔Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
📍 Fox Chase Cancer Center - Philadelphia — Philadelphia, Pennsylvania
Primary Myelofibrosis
View Study & Checklist ➔Talazoparib and Thoracic RT for ES-SCLC
📍 Princess Margaret Cancer Center, University Health Network — Toronto, Ontario
Lung Cancer
View Study & Checklist ➔TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
Lymphoma, Non-Hodgkin
View Study & Checklist ➔Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
📍 Phoenix Children's Hospital — Phoenix, Arizona
Acute Myeloid Leukemia
View Study & Checklist ➔